Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Asset Writedowns and Impairment: 2017-2024

  • Mesa Laboratories' Asset Writedowns and Impairment was N/A to $274.5 million in Q1 2024 from the same period last year, while for Mar 2024 it was $279.6 million, marking a year-over-year change of. This contributed to the annual value of $274.5 million for FY2024, which is N/A change from last year.
  • Mesa Laboratories' Asset Writedowns and Impairment amounted to $274.5 million in Q1 2024, which was up 99,368.48% from $276,000 recorded in Q4 2019.
  • Mesa Laboratories' Asset Writedowns and Impairment's 5-year high stood at $274.5 million during Q1 2024, with a 5-year trough of $274.5 million in Q1 2024.
  • Over the past 1 years, Mesa Laboratories' median Asset Writedowns and Impairment value was $274.5 million (recorded in 2024), while the average stood at $274.5 million.